{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T18:39:02Z","timestamp":1781375942529,"version":"3.54.1"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-03003-5","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:35:28Z","timestamp":1734050128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Contemplating Novel W\/O Emulsion Based Gel for Anti-Psoriatic Activity of Tofacitinib in Imiquimod-Induced Balb\/C Mice Model"],"prefix":"10.1208","volume":"26","author":[{"given":"Ashwini","family":"Aratwar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Indrani","family":"Maji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrilekha","family":"Chilvery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srushti","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Aalhate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujala","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandraiah","family":"Godugu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8462-2170","authenticated-orcid":false,"given":"Pankaj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,13]]},"reference":[{"key":"3003_CR1","unstructured":"World Health Organization. Psoriasis. 2013. https:\/\/apps.who.int\/gb\/ebwha\/pdf_files\/EB133\/B133_5-en.pdf. Accessed\u00a0Dec 2022"},{"key":"3003_CR2","unstructured":"National Institute of Health N. Psoriasis. https:\/\/www.niams.nih.gov\/health-topics\/psoriasis. Accessed 2022"},{"issue":"5","key":"3003_CR3","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jaad.2013.06.027","volume":"69","author":"A Mason","year":"2013","unstructured":"Mason A, et al. Topical treatments for chronic plaque psoriasis: an abridged Cochrane systematic review. J Am Acad Dermatol. 2013;69(5):799\u2013807.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"3003_CR4","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1517\/14656566.2010.492778","volume":"11","author":"PM Laws","year":"2010","unstructured":"Laws PM, Young HS. Topical treatment of psoriasis. Expert Opin Pharmacother. 2010;11(12):1999\u20132009.","journal-title":"Expert Opin Pharmacother"},{"issue":"19","key":"3003_CR5","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360.","journal-title":"JAMA"},{"key":"3003_CR6","unstructured":"Dutta S, Chawla S, Kumar S. Psoriasis: A review of existing therapies and recent advances in treatment. differentiation, 2018. 2(10)."},{"issue":"3","key":"3003_CR7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/biom11030371","volume":"11","author":"F Gendrisch","year":"2021","unstructured":"Gendrisch F, et al. The effect of herbal medicinal products on psoriasis-like keratinocytes. Biomolecules. 2021;11(3):371.","journal-title":"Biomolecules"},{"issue":"12","key":"3003_CR8","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.drudis.2020.09.023","volume":"25","author":"VK Rapalli","year":"2020","unstructured":"Rapalli VK, et al. Psoriasis: pathological mechanisms, current pharmacological therapies, and emerging drug delivery systems. Drug Discovery Today. 2020;25(12):2212\u201326.","journal-title":"Drug Discovery Today"},{"issue":"4","key":"3003_CR9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5114\/reum.2018.77971","volume":"56","author":"EJ Kucharz","year":"2018","unstructured":"Kucharz EJ, et al. Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology. Reumatologia\/Rheumatology. 2018;56(4):203\u201311.","journal-title":"Reumatologia\/Rheumatology"},{"key":"3003_CR10","unstructured":"FDA. XELJANZ (tofacitinib). 2018."},{"key":"3003_CR11","doi-asserted-by":"crossref","unstructured":"Frede N et al. Psoriasis and Psoriatic Arthritis Have a Major Impact on Quality of Life and Depressive Symptoms: A Cross-Sectional Study of 300 Patients. Rheumatology and Therapy, 2023: pp. 1\u201314.","DOI":"10.1007\/s40744-023-00602-9"},{"issue":"10","key":"3003_CR12","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1080\/14656566.2016.1195812","volume":"17","author":"M Galluzzo","year":"2016","unstructured":"Galluzzo M, et al. Tofacitinib for the treatment of psoriasis. Expert Opin Pharmacother. 2016;17(10):1421\u201333.","journal-title":"Expert Opin Pharmacother"},{"key":"3003_CR13","unstructured":"Khaparkhuntikar K et al. Acalabrutinib as a novel hope for the treatment of breast and lung cancer: an in-silico proof of concept. J Biomol Struct Dynamics, 2023: pp. 1\u201316."},{"issue":"12","key":"3003_CR14","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1517\/17425247.2014.938634","volume":"11","author":"R Sonawane","year":"2014","unstructured":"Sonawane R, et al. Solid lipid nanoparticles-loaded topical gel containing combination drugs: an approach to offset psoriasis. Expert Opin Drug Deliv. 2014;11(12):1833\u201347.","journal-title":"Expert Opin Drug Deliv"},{"issue":"6","key":"3003_CR15","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1177\/0300060519847414","volume":"47","author":"F Tian","year":"2019","unstructured":"Tian F, Chen Z, Xu T. Efficacy and safety of tofacitinib for the treatment of chronic plaque psoriasis: a systematic review and meta-analysis. J Int Med Res. 2019;47(6):2342\u201350.","journal-title":"J Int Med Res"},{"key":"3003_CR16","doi-asserted-by":"crossref","first-page":"104789","DOI":"10.1016\/j.jddst.2023.104789","volume":"87","author":"H Roy","year":"2023","unstructured":"Roy H, et al. N-trimethyl chitosan and tripalmitin loaded solid lipid nanoparticles of tofacitinib citrate: characterization and in-vivo anti-inflammatory assessment. J Drug Deliv Sci Technol. 2023;87:104789.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3003_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/bjd.12266","volume":"169","author":"W Ports","year":"2013","unstructured":"Ports W, et al. A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis. Br J Dermatol. 2013;169(1):137\u201345.","journal-title":"Br J Dermatol"},{"key":"3003_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.biopha.2018.07.156","volume":"107","author":"M Pradhan","year":"2018","unstructured":"Pradhan M, et al. Understanding the prospective of nano-formulations towards the treatment of psoriasis. Biomed Pharmacother. 2018;107:447\u201363.","journal-title":"Biomed Pharmacother"},{"key":"3003_CR19","first-page":"75","volume-title":"Nanocarriers for topical delivery in psoriasis, in Delivery of drugs","author":"G Singhvi","year":"2020","unstructured":"Singhvi G, et al. Nanocarriers for topical delivery in psoriasis, in delivery of drugs. Elsevier; 2020. pp. 75\u201396."},{"key":"3003_CR20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/978-3-031-30529-0_2","volume-title":"Polymeric Nanomaterials: Fundamentals and Therapeutic Applications, in Nanomaterial-Based Drug Delivery Systems: Therapeutic and Theranostic Applications","author":"I Maji","year":"2023","unstructured":"Maji I, et al. Polymeric nanomaterials: fundamentals and therapeutic applications, in Nanomaterial-based drug Delivery systems: therapeutic and theranostic applications. Springer; 2023. pp. 33\u201364."},{"key":"3003_CR21","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-031-30529-0_4","volume-title":"Vesicular Nanomaterials: Types and Therapeutic Uses, in Nanomaterial-Based Drug Delivery Systems: Therapeutic and Theranostic Applications","author":"S Mahajan","year":"2023","unstructured":"Mahajan S, et al. Vesicular nanomaterials: types and therapeutic uses, in Nanomaterial-based drug Delivery systems: therapeutic and theranostic applications. Springer; 2023. pp. 99\u2013145."},{"issue":"10","key":"3003_CR22","first-page":"148","volume":"2","author":"MS Alam","year":"2012","unstructured":"Alam MS, et al. Design and characterization of nanostructure topical gel of betamethasone dipropionate for psoriasis. J Appl Pharm Sci. 2012;2(10):148\u201358.","journal-title":"J Appl Pharm Sci"},{"key":"3003_CR23","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jconrel.2021.08.013","volume":"337","author":"I Maji","year":"2021","unstructured":"Maji I, et al. Solid self emulsifying drug delivery system: Superior mode for oral delivery of hydrophobic cargos. J Controlled Release. 2021;337:646\u201360.","journal-title":"J Controlled Release"},{"key":"3003_CR24","doi-asserted-by":"crossref","unstructured":"Prajapat VM et al. Amphotericin B loaded nanoemulsion: Optimization, characterization and in-vitro activity against L. donovani promastigotes. Parasitology International, 2023: p. 102848.","DOI":"10.1016\/j.parint.2023.102848"},{"issue":"1\u20132","key":"3003_CR25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijpharm.2017.04.068","volume":"526","author":"P Sengupta","year":"2017","unstructured":"Sengupta P, Chatterjee B. Potential and future scope of nanoemulgel formulation for topical delivery of lipophilic drugs. Int J Pharm. 2017;526(1\u20132):353\u201365.","journal-title":"Int J Pharm"},{"issue":"2","key":"3003_CR26","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jconrel.2013.06.030","volume":"171","author":"A Alexander","year":"2013","unstructured":"Alexander A, et al. Recent expansions in an emergent novel drug delivery technology: Emulgel. J Controlled Release. 2013;171(2):122\u201332.","journal-title":"J Controlled Release"},{"key":"3003_CR27","doi-asserted-by":"crossref","first-page":"103181","DOI":"10.1016\/j.jddst.2022.103181","volume":"69","author":"B Prajapati","year":"2022","unstructured":"Prajapati B, et al. Strategy to counteract the pyrazinamide induced hepatotoxicity by developing naringin based co-amorphous system with supplementary benefits. J Drug Deliv Sci Technol. 2022;69:103181.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"3003_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1080\/03639045.2019.1576722","volume":"45","author":"P Sathe","year":"2019","unstructured":"Sathe P, et al. Dithranol-loaded nanostructured lipid carrier-based gel ameliorate psoriasis in imiquimod-induced mice psoriatic plaque model. Drug Dev Ind Pharm. 2019;45(5):826\u201338.","journal-title":"Drug Dev Ind Pharm"},{"key":"3003_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.9780\/2249-894X\/262013\/262","volume":"2","author":"TK Marwaha","year":"2013","unstructured":"Marwaha TK. Formulation Development of anti-psoriatic Topical Babchi Oil Emulgel. Res Rev: J Herb Sci. 2013;2:1\u201310.","journal-title":"Res Rev: J Herb Sci"},{"key":"3003_CR30","first-page":"1","volume-title":"Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-, ex-vivo and in-vivo pharmacokinetic evaluation","author":"MAM Ateeq","year":"2023","unstructured":"Ateeq MAM, et al. Self-nanoemulsifying drug delivery system (SNEDDS) of docetaxel and carvacrol synergizes the anticancer activity and enables safer toxicity profile: optimization, and in-, ex-vivo and in-vivo pharmacokinetic evaluation. Drug Delivery and Translational Research; 2023. pp. 1\u201325."},{"key":"3003_CR31","doi-asserted-by":"crossref","first-page":"104321","DOI":"10.1016\/j.jddst.2023.104321","volume":"82","author":"M Tamizhmathy","year":"2023","unstructured":"Tamizhmathy M, et al. Formulation of inclusion complex of abiraterone acetate with 2-Hydroxypropyl-Beta-cyclodextrin: physiochemical characterization, molecular docking and bioavailability evaluation. J Drug Deliv Sci Technol. 2023;82:104321.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3003_CR32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5530\/ijper.54.2.38","volume":"54","author":"SD Acharya","year":"2020","unstructured":"Acharya SD, et al. QbD based optimization of curcumin nanoemulsion: DoE and cytotoxicity studies. Indian J Pharm Educ Res. 2020;54:329\u201336.","journal-title":"Indian J Pharm Educ Res"},{"issue":"3","key":"3003_CR33","doi-asserted-by":"crossref","first-page":"415","DOI":"10.12991\/mpj.20162084614","volume":"20","author":"V Shah","year":"2016","unstructured":"Shah V, et al. Quality by design (QbD) approach for optimization of microemulsion based topical gel. Marmara Pharm J. 2016;20(3):415\u201324.","journal-title":"Marmara Pharm J"},{"key":"3003_CR34","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s12247-019-09420-5","volume":"16","author":"Ameeduzzafar","year":"2021","unstructured":"Ameeduzzafar, et al. BBD-based development of itraconazole loaded nanostructured lipid carrier for topical delivery: in vitro evaluation and antimicrobial assessment. J Pharm Innov. 2021;16:85\u201398.","journal-title":"J Pharm Innov"},{"issue":"1","key":"3003_CR35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jsps.2011.08.001","volume":"20","author":"R Khullar","year":"2012","unstructured":"Khullar R, et al. Formulation and evaluation of mefenamic acid emulgel for topical delivery. Saudi Pharm J. 2012;20(1):63\u20137.","journal-title":"Saudi Pharm J"},{"issue":"4","key":"3003_CR36","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5530\/ijper.51.4.81","volume":"51","author":"NP Ambhore","year":"2017","unstructured":"Ambhore NP, et al. Formulation and characterization of tapentadol loaded emulgel for topical application. Indian J Pharm Educ Res. 2017;51(4):525\u201335.","journal-title":"Indian J Pharm Educ Res"},{"key":"3003_CR37","doi-asserted-by":"crossref","first-page":"101847","DOI":"10.1016\/j.jddst.2020.101847","volume":"59","author":"MS Algahtani","year":"2020","unstructured":"Algahtani MS, Ahmad MZ, Ahmad J. Nanoemulsion loaded polymeric hydrogel for topical delivery of curcumin in psoriasis. J Drug Deliv Sci Technol. 2020;59:101847.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"5","key":"3003_CR38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/10837450.2023.2206668","volume":"28","author":"A Dhuri","year":"2023","unstructured":"Dhuri A, et al. Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy. Pharm Dev Technol. 2023;28(5):460\u201378.","journal-title":"Pharm Dev Technol"},{"key":"3003_CR39","doi-asserted-by":"crossref","first-page":"113631","DOI":"10.1016\/j.colsurfb.2023.113631","volume":"233","author":"BN Saren","year":"2024","unstructured":"Saren BN, et al. Fucoidan-mediated targeted delivery of dasatinib-loaded nanoparticles amplifies apoptosis and endows cytotoxic potential in triple-negative breast cancer. Colloids Surf B. 2024;233:113631.","journal-title":"Colloids Surf B"},{"issue":"8","key":"3003_CR40","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1080\/03639045.2022.2119572","volume":"48","author":"S Nishal","year":"2022","unstructured":"Nishal S, et al. In vitro characterization of tofacitinib loaded novel nanoemulgel for topical delivery for the management of rheumatic arthritis. Drug Dev Ind Pharm. 2022;48(8):374\u201383.","journal-title":"Drug Dev Ind Pharm"},{"key":"3003_CR41","doi-asserted-by":"crossref","first-page":"104145","DOI":"10.1016\/j.jddst.2022.104145","volume":"80","author":"S Atmakuri","year":"2023","unstructured":"Atmakuri S, et al. Topical delivery of tofacitinib citrate loaded novel nanoemulgel for the management of 2, 4-Dichlorodinitrobenzene induced atopic dermatitis in mice model. J Drug Deliv Sci Technol. 2023;80:104145.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3003_CR42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.lfs.2015.10.001","volume":"141","author":"RK Harwansh","year":"2015","unstructured":"Harwansh RK, et al. Enhanced permeability of ferulic acid loaded nanoemulsion based gel through skin against UVA mediated oxidative stress. Life Sci. 2015;141:202\u201311.","journal-title":"Life Sci"},{"issue":"4","key":"3003_CR43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4274\/tjps.galenos.2020.33239","volume":"18","author":"J Sainy","year":"2021","unstructured":"Sainy J, Atneriya U, MAHESHWARI R. Development of an Aloe vera-based Emulgel for the topical delivery of Desoximetasone. Turkish J Pharm Sci. 2021;18(4):465.","journal-title":"Turkish J Pharm Sci"},{"issue":"1\u20132","key":"3003_CR44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ijpharm.2015.04.015","volume":"487","author":"S Pund","year":"2015","unstructured":"Pund S, et al. Transcutaneous delivery of leflunomide nanoemulgel: mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. Int J Pharm. 2015;487(1\u20132):148\u201356.","journal-title":"Int J Pharm"},{"key":"3003_CR45","doi-asserted-by":"crossref","unstructured":"Rao M et al. Optimization of metronidazole emulgel. Journal of pharmaceutics, 2013. 2013.","DOI":"10.1155\/2013\/501082"},{"key":"3003_CR46","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10847-013-0293-2","volume":"78","author":"U Badilli","year":"2014","unstructured":"Badilli U, et al. Topical emulgel formulation containing inclusion complex of calcipotriol with cyclodextrin. J Incl Phenom Macrocyclic Chem. 2014;78:249\u201355.","journal-title":"J Incl Phenom Macrocyclic Chem"},{"issue":"1\u20132","key":"3003_CR47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijpharm.2014.10.005","volume":"477","author":"L Zhao","year":"2014","unstructured":"Zhao L, et al. Ropivacaine loaded microemulsion and microemulsion-based gel for transdermal delivery: preparation, optimization, and evaluation. Int J Pharm. 2014;477(1\u20132):47\u201356.","journal-title":"Int J Pharm"},{"key":"3003_CR48","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejps.2016.10.025","volume":"96","author":"S Doppalapudi","year":"2017","unstructured":"Doppalapudi S, et al. Psoralen loaded liposomal nanocarriers for improved skin penetration and efficacy of topical PUVA in psoriasis. Eur J Pharm Sci. 2017;96:515\u201329.","journal-title":"Eur J Pharm Sci"},{"key":"3003_CR49","doi-asserted-by":"crossref","unstructured":"Jain A et al. Liposphere mediated topical delivery of thymoquinone in the treatment of psoriasis. Nanomedicine: Nanotechnology, Biology and Medicine, 2017. 13(7): pp. 2251\u20132262.","DOI":"10.1016\/j.nano.2017.06.009"},{"key":"3003_CR50","doi-asserted-by":"crossref","first-page":"103103","DOI":"10.1016\/j.jddst.2022.103103","volume":"68","author":"H Jain","year":"2022","unstructured":"Jain H, et al. Liposome mediated topical delivery of Ibrutinib and Curcumin as a synergistic approach to combat imiquimod induced psoriasis. J Drug Deliv Sci Technol. 2022;68:103103.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3003_CR51","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1080\/10717544.2021.2015483","volume":"29","author":"BA Khan","year":"2022","unstructured":"Khan BA, et al. Carbopol emulgel loaded with ebastine for urticaria: development, characterization, in vitro and in vivo evaluation. Drug Delivery. 2022;29(1):52\u201361.","journal-title":"Drug Delivery"},{"key":"3003_CR52","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jconrel.2016.10.004","volume":"243","author":"A Jain","year":"2016","unstructured":"Jain A, et al. Tacrolimus and Curcumin co-loaded liposphere gel: synergistic combination towards management of psoriasis. J Controlled Release. 2016;243:132\u201345.","journal-title":"J Controlled Release"},{"issue":"1","key":"3003_CR53","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-019-2212-y","volume":"11","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda S, et al. Piperlongumine regulates epigenetic modulation and alleviates psoriasis-like skin inflammation via inhibition of hyperproliferation and inflammation. Cell Death Dis. 2020;11(1):21.","journal-title":"Cell Death Dis"},{"issue":"6","key":"3003_CR54","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1002\/jcp.29413","volume":"235","author":"S Thatikonda","year":"2020","unstructured":"Thatikonda S, Pooladanda V, Godugu C. Repurposing an old drug for new use: Niclosamide in psoriasis-like skin inflammation. J Cell Physiol. 2020;235(6):5270\u201383.","journal-title":"J Cell Physiol"},{"key":"3003_CR55","doi-asserted-by":"crossref","first-page":"106909","DOI":"10.1016\/j.intimp.2020.106909","volume":"88","author":"S Chilvery","year":"2020","unstructured":"Chilvery S, et al. Piperlongumine attenuates bile duct ligation-induced liver fibrosis in mice via inhibition of TGF-\u03b21\/Smad and EMT pathways. Int Immunopharmacol. 2020;88:106909.","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"3003_CR56","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3390\/gels9020112","volume":"9","author":"R Khan","year":"2023","unstructured":"Khan R, et al. Vitro and in vivo investigation of a dual-targeted Nanoemulsion Gel for the amelioration of Psoriasis. Gels. 2023;9(2):112.","journal-title":"Gels"},{"issue":"7","key":"3003_CR57","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/ijms23073798","volume":"23","author":"E He","year":"2022","unstructured":"He E, et al. Transdermal delivery of indirubin-loaded microemulsion gel: preparation, characterization and anti-psoriatic activity. Int J Mol Sci. 2022;23(7):3798.","journal-title":"Int J Mol Sci"},{"key":"3003_CR58","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.ijbiomac.2018.08.136","volume":"120","author":"P Tripathi","year":"2018","unstructured":"Tripathi P, et al. Carbomer gel bearing methotrexate loaded lipid nanocontainers shows improved topical delivery intended for effective management of psoriasis. Int J Biol Macromol. 2018;120:1322\u201334.","journal-title":"Int J Biol Macromol"},{"issue":"4","key":"3003_CR59","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.nano.2017.02.009","volume":"13","author":"A Kaur","year":"2017","unstructured":"Kaur A, et al. Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis. Nanomed Nanotechnol Biol Med. 2017;13(4):1473\u201382.","journal-title":"Nanomed Nanotechnol Biol Med"},{"key":"3003_CR60","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5530\/ijper.51.4.81","volume":"51","author":"NP Ambhore","year":"2017","unstructured":"Ambhore NP, et al. Formulation and characterization of tapentadol loaded emulgel for topical application. Indian J Pharm Educ Res. 2017;51:525\u201335.","journal-title":"Indian J Pharm Educ Res"},{"key":"3003_CR61","first-page":"113559","volume-title":"Peppermint essential oil: Its phytochemistry, biological activity, pharmacological effect and application","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application. Volume 154. Biomedicine & pharmacotherapy; 2022. p. 113559."},{"key":"3003_CR62","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1208\/s12249-018-1196-8","volume":"19","author":"DW Osborne","year":"2018","unstructured":"Osborne DW, Musakhanian J. Skin penetration and permeation properties of Transcutol\u00ae\u2014neat or diluted mixtures. AAPS PharmSciTech. 2018;19:3512\u201333.","journal-title":"AAPS PharmSciTech"},{"issue":"4","key":"3003_CR63","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/pharmaceutics13040542","volume":"13","author":"A Patel","year":"2021","unstructured":"Patel A, et al. In vitro\u2013in vivo correlation in dermal delivery: the role of excipients. Pharmaceutics. 2021;13(4):542.","journal-title":"Pharmaceutics"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-03003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-03003-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-03003-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:26:54Z","timestamp":1739993214000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-03003-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["3003"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-03003-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]},"assertion":[{"value":"22 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}},{"value":"This study was conducted in accordance with all the institutional and national\u00a0ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"12"}}